Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStill feeling hungry on Wegovy is more common than most people expect, and it rarely means the medicine isn't working. Semaglutide reduces appetite by acting on GLP-1 receptors in the brain and gut, but that effect builds gradually — and several factors can blunt or delay it. The core question worth asking is not whether hunger is present, but what kind of hunger it is, and whether something practical is undermining the medicine's effect. These are prescription-only medicines; a GPhC-registered prescriber assesses whether your current dose and approach are right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The titration schedule for Wegovy starts at 0.25mg and climbs through 0.5mg, 1.0mg and 1.7mg before reaching the 2.4mg maintenance dose, with roughly four weeks at each level. At the lower rungs, most people notice only a modest reduction in appetite. That is by design: the slower climb reduces nausea, not hunger. So if you are still on a starter or intermediate dose, the honest answer is that the full effect simply has not arrived yet.
Once you reach 2.4mg and stay there for several weeks, appetite suppression tends to deepen. The Wegovy overview on our treatment pages explains how the medicine works and what the maintenance phase involves. If you have been on 2.4mg for more than six weeks and still feel as hungry as before treatment, that is worth flagging to your prescriber, it is a genuinely useful data point, not a complaint. Our page on why you might still feel hungry on Wegovy after several weeks covers what to expect once you are established on the maintenance dose and when the situation warrants a clinical conversation. MHRA-approved guidance covers what to do when appetite control feels insufficient, and a prescriber can assess whether the dose is being absorbed and working as expected.
One quick check worth doing: look at when you inject relative to your hungriest part of the day. Semaglutide peaks in the bloodstream roughly 24–72 hours after injection. Switching your injection day so that the peak lands mid-week, when your schedule is most demanding, costs nothing and takes under a minute to work out.
Semaglutide acts on GLP-1 receptors in the hypothalamus and brainstem, areas involved in reading genuine energy signals from the body. It is considerably less effective at quieting appetite that is driven by habit, boredom, stress or the sight of food. Researchers and clinicians often call this distinction "head hunger" versus "body hunger," and the two feel almost indistinguishable in the moment.
A useful test: wait ten minutes and drink a large glass of water. True hunger grows stronger; head hunger often fades or becomes manageable. This is not a trick, it works because thirst and mild dehydration can produce sensations that mimic early hunger, and because a short pause interrupts the automatic reach for food that habit drives. If you are wondering why you are still feeling hungry on Wegovy despite being on an active dose, the distinction between body hunger and head hunger is often at the heart of the answer. People using semaglutide for weight loss frequently report that the medicine suppresses body hunger effectively but leaves emotional and habitual eating largely intact, at least at first.
Practical strategies that tend to help: eating more slowly (the brain's fullness signal lags the stomach by roughly 20 minutes), structuring meals rather than grazing, and being deliberate about sleep, poor sleep elevates ghrelin, the hunger hormone, in a way that can override semaglutide's effect by morning. None of these are willpower exercises; they are physiological adjustments that work with the medicine rather than against it.
This matters more on Wegovy than most people realise. When overall food intake drops significantly, the risk of losing muscle alongside fat increases. Muscle loss then lowers the metabolic rate, which paradoxically can make hunger signals stronger over time as the body tries to recalibrate. The NHS's guidance on healthy weight and diet underlines the importance of protein adequacy and physical activity during any period of reduced calorie intake.
Aiming for protein at every meal (eggs, fish, chicken, legumes, Greek yoghurt) supports muscle retention and produces stronger satiety signals than carbohydrates or fats at the same calorie level. If your meals are largely carbohydrate-based, hunger can return faster after eating even when Wegovy is working well. Our guide to eating on Wegovy covers practical meal structures that support the medicine.
For detailed information on how semaglutide works and its known effects on appetite, the NHS semaglutide page is a reliable starting point. It is worth reading before your next clinical review so you can ask specific questions.
Hunger that gradually eases over weeks is normal. Hunger that has not changed at all after two or three months on the maintenance dose is a clinical signal. There may be a straightforward explanation, poor injection technique, storage outside the recommended temperature range, or an interaction with another medicine affecting absorption. There may also be a dose-related conversation to have.
If hunger is accompanied by low mood, fatigue or a sense that nothing is working, it is especially worth talking to someone. Persistent hunger on Wegovy has several distinct causes, and a prescriber who knows your history can usually narrow it down quickly. You can also explore what other people ask about this on our frequently asked questions page, or contact our team directly if you have a specific concern between reviews.
At nume, every repeat order is clinically re-reviewed before dispatch, there is no auto-renewal that skips a clinical eye. If your hunger pattern has changed, that review is the right place to say so. To speak to our prescribers about whether your current plan is working as well as it could, start a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.